Among the 203 patients with p16-negative locally advanced head and neck squamous cell carcinoma, the tumors in 16 patients (8%) were categorized as AJCC 7th stage III disease, 89 patients (44%) as stage IVA, and 98 (48%) as stage IVB. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.